Regulation and degradation of HMGCo-A reductase View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2004-09-30

AUTHORS

T. Panda, V. Amutha Devi

ABSTRACT

The enzyme, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) controls the biosynthesis of cholesterol. Hypercholesterolemia and atherosclerosis are critical health risk factors. One way of controlling these risk factors is to manipulate regulation as well as degradation of HMGR. At present, a class of compounds called statins, which are HMGR inhibitors, are used for the treatment of hypercholesterolemia. However, statins suffer major setbacks as their use produces more adverse reactions than the desirable one of inhibiting the enzyme. Genetically engineered forms of HMGR are also studied in primitive life forms like bacteria, but detailed investigation of this enzyme in human systems is certainly required. Extensive studies have been made on the regulatory aspects of this enzyme, but no breakthrough is conspicuous in the clinical background to find an alternative treatment for hypercholesterolemia. The immediate need is to find an alternate way of regulating degradation of the enzyme. This review presents the importance of regulation and degradation of the HMGR enzyme in different systems to gain possible insight into alternative schemes for regulating this enzyme and, if these exist, the feasibility of extending them same to studies in mammalian systems. A high degree of similarity exists between mammalian and yeast HMGR. Detailed studies reported on the regulation and degradation of the yeast enzyme also throw more light on the mammalian system, leading to a better understanding of ways of controlling hypercholesterolemia. More... »

PAGES

143-152

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00253-004-1720-5

DOI

http://dx.doi.org/10.1007/s00253-004-1720-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030570228

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15558272


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxymethylglutaryl CoA Reductases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mevalonic Acid", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Chemical Engineering, Indian Institute of Technology, Madras, 600 036, Chennai, India", 
          "id": "http://www.grid.ac/institutes/grid.417969.4", 
          "name": [
            "Department of Chemical Engineering, Indian Institute of Technology, Madras, 600 036, Chennai, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Panda", 
        "givenName": "T.", 
        "id": "sg:person.01002553400.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002553400.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemical Engineering, Indian Institute of Technology, Madras, 600 036, Chennai, India", 
          "id": "http://www.grid.ac/institutes/grid.417969.4", 
          "name": [
            "Department of Chemical Engineering, Indian Institute of Technology, Madras, 600 036, Chennai, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Devi", 
        "givenName": "V. Amutha", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/343425a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047196635", 
          "https://doi.org/10.1038/343425a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/308613a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030470122", 
          "https://doi.org/10.1038/308613a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00023395", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022278703", 
          "https://doi.org/10.1007/bf00023395"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2004-09-30", 
    "datePublishedReg": "2004-09-30", 
    "description": "The enzyme, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) controls the biosynthesis of cholesterol. Hypercholesterolemia and atherosclerosis are critical health risk factors. One way of controlling these risk factors is to manipulate regulation as well as degradation of HMGR. At present, a class of compounds called statins, which are HMGR inhibitors, are used for the treatment of hypercholesterolemia. However, statins suffer major setbacks as their use produces more adverse reactions than the desirable one of inhibiting the enzyme. Genetically engineered forms of HMGR are also studied in primitive life forms like bacteria, but detailed investigation of this enzyme in human systems is certainly required. Extensive studies have been made on the regulatory aspects of this enzyme, but no breakthrough is conspicuous in the clinical background to find an alternative treatment for hypercholesterolemia. The immediate need is to find an alternate way of regulating degradation of the enzyme. This review presents the importance of regulation and degradation of the HMGR enzyme in different systems to gain possible insight into alternative schemes for regulating this enzyme and, if these exist, the feasibility of extending them same to studies in mammalian systems. A high degree of similarity exists between mammalian and yeast HMGR. Detailed studies reported on the regulation and degradation of the yeast enzyme also throw more light on the mammalian system, leading to a better understanding of ways of controlling hypercholesterolemia.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00253-004-1720-5", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1083533", 
        "issn": [
          "0175-7598", 
          "1432-0614"
        ], 
        "name": "Applied Microbiology and Biotechnology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "66"
      }
    ], 
    "keywords": [
      "mammalian systems", 
      "degradation of HMGR", 
      "primitive life forms", 
      "yeast enzyme", 
      "HMGR enzyme", 
      "life forms", 
      "biosynthesis of cholesterol", 
      "HMGR inhibitors", 
      "HMGR", 
      "importance of regulation", 
      "enzyme", 
      "regulation", 
      "reductase", 
      "regulatory aspects", 
      "mammalian", 
      "degradation", 
      "biosynthesis", 
      "possible insights", 
      "human systems", 
      "bacteria", 
      "better understanding", 
      "extensive study", 
      "high degree", 
      "coenzyme", 
      "more light", 
      "inhibitors", 
      "similarity", 
      "class of compounds", 
      "detailed study", 
      "insights", 
      "factors", 
      "form", 
      "detailed investigation", 
      "understanding", 
      "major setback", 
      "study", 
      "treatment of hypercholesterolemia", 
      "importance", 
      "light", 
      "immediate need", 
      "different systems", 
      "compounds", 
      "system", 
      "review", 
      "breakthrough", 
      "atherosclerosis", 
      "present", 
      "treatment", 
      "cholesterol", 
      "class", 
      "aspects", 
      "reaction", 
      "background", 
      "way", 
      "investigation", 
      "degree", 
      "hypercholesterolemia", 
      "use", 
      "statins", 
      "alternate way", 
      "need", 
      "setback", 
      "alternative scheme", 
      "feasibility", 
      "risk factors", 
      "alternative treatment", 
      "health risk factors", 
      "clinical background", 
      "scheme", 
      "adverse reactions", 
      "critical health risk factors", 
      "forms of HMGR", 
      "yeast HMGR", 
      "degradation of HMGCo", 
      "HMGCo"
    ], 
    "name": "Regulation and degradation of HMGCo-A reductase", 
    "pagination": "143-152", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030570228"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00253-004-1720-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15558272"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00253-004-1720-5", 
      "https://app.dimensions.ai/details/publication/pub.1030570228"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_389.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00253-004-1720-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00253-004-1720-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00253-004-1720-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00253-004-1720-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00253-004-1720-5'


 

This table displays all metadata directly associated to this object as RDF triples.

179 TRIPLES      22 PREDICATES      110 URIs      99 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00253-004-1720-5 schema:about N0eb10b49d7c74d7bb10be40d0903f333
2 Ncde3a1d2044a4c7788575b7c6e838c3c
3 Nd0849522413b452baa75a30c56c5e8b0
4 Ne8dc542f1af747a18e3cd4a960683d7f
5 Nf9b14a0a9617476180d0c4cfb4564b3d
6 Nfe02af8b79914ab8b821c54363b2ac19
7 anzsrc-for:06
8 anzsrc-for:0601
9 schema:author N26375f1810084a27a544a2c330187e05
10 schema:citation sg:pub.10.1007/bf00023395
11 sg:pub.10.1038/308613a0
12 sg:pub.10.1038/343425a0
13 schema:datePublished 2004-09-30
14 schema:datePublishedReg 2004-09-30
15 schema:description The enzyme, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) controls the biosynthesis of cholesterol. Hypercholesterolemia and atherosclerosis are critical health risk factors. One way of controlling these risk factors is to manipulate regulation as well as degradation of HMGR. At present, a class of compounds called statins, which are HMGR inhibitors, are used for the treatment of hypercholesterolemia. However, statins suffer major setbacks as their use produces more adverse reactions than the desirable one of inhibiting the enzyme. Genetically engineered forms of HMGR are also studied in primitive life forms like bacteria, but detailed investigation of this enzyme in human systems is certainly required. Extensive studies have been made on the regulatory aspects of this enzyme, but no breakthrough is conspicuous in the clinical background to find an alternative treatment for hypercholesterolemia. The immediate need is to find an alternate way of regulating degradation of the enzyme. This review presents the importance of regulation and degradation of the HMGR enzyme in different systems to gain possible insight into alternative schemes for regulating this enzyme and, if these exist, the feasibility of extending them same to studies in mammalian systems. A high degree of similarity exists between mammalian and yeast HMGR. Detailed studies reported on the regulation and degradation of the yeast enzyme also throw more light on the mammalian system, leading to a better understanding of ways of controlling hypercholesterolemia.
16 schema:genre article
17 schema:inLanguage en
18 schema:isAccessibleForFree false
19 schema:isPartOf N4bc6e2cb17344e168ffdaf83945b1ccf
20 Ne24fca86051e45d9908dae789dab98c8
21 sg:journal.1083533
22 schema:keywords HMGCo
23 HMGR
24 HMGR enzyme
25 HMGR inhibitors
26 adverse reactions
27 alternate way
28 alternative scheme
29 alternative treatment
30 aspects
31 atherosclerosis
32 background
33 bacteria
34 better understanding
35 biosynthesis
36 biosynthesis of cholesterol
37 breakthrough
38 cholesterol
39 class
40 class of compounds
41 clinical background
42 coenzyme
43 compounds
44 critical health risk factors
45 degradation
46 degradation of HMGCo
47 degradation of HMGR
48 degree
49 detailed investigation
50 detailed study
51 different systems
52 enzyme
53 extensive study
54 factors
55 feasibility
56 form
57 forms of HMGR
58 health risk factors
59 high degree
60 human systems
61 hypercholesterolemia
62 immediate need
63 importance
64 importance of regulation
65 inhibitors
66 insights
67 investigation
68 life forms
69 light
70 major setback
71 mammalian
72 mammalian systems
73 more light
74 need
75 possible insights
76 present
77 primitive life forms
78 reaction
79 reductase
80 regulation
81 regulatory aspects
82 review
83 risk factors
84 scheme
85 setback
86 similarity
87 statins
88 study
89 system
90 treatment
91 treatment of hypercholesterolemia
92 understanding
93 use
94 way
95 yeast HMGR
96 yeast enzyme
97 schema:name Regulation and degradation of HMGCo-A reductase
98 schema:pagination 143-152
99 schema:productId Na9b8fd2f335d4fd0b4ec122797f2be90
100 Nb69cb01dec50439195918c6552f296b3
101 Nc4e2d82eb5d04707897e9b6d56a32795
102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030570228
103 https://doi.org/10.1007/s00253-004-1720-5
104 schema:sdDatePublished 2022-01-01T18:14
105 schema:sdLicense https://scigraph.springernature.com/explorer/license/
106 schema:sdPublisher N908d16fd46f945a5b62a0369e8131ad2
107 schema:url https://doi.org/10.1007/s00253-004-1720-5
108 sgo:license sg:explorer/license/
109 sgo:sdDataset articles
110 rdf:type schema:ScholarlyArticle
111 N0eb10b49d7c74d7bb10be40d0903f333 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Mevalonic Acid
113 rdf:type schema:DefinedTerm
114 N26375f1810084a27a544a2c330187e05 rdf:first sg:person.01002553400.17
115 rdf:rest N3f533a80fc384b449fccb3eaf435e505
116 N3f533a80fc384b449fccb3eaf435e505 rdf:first N3f8d8ea752674d8eb3876cb09553136e
117 rdf:rest rdf:nil
118 N3f8d8ea752674d8eb3876cb09553136e schema:affiliation grid-institutes:grid.417969.4
119 schema:familyName Devi
120 schema:givenName V. Amutha
121 rdf:type schema:Person
122 N4bc6e2cb17344e168ffdaf83945b1ccf schema:issueNumber 2
123 rdf:type schema:PublicationIssue
124 N908d16fd46f945a5b62a0369e8131ad2 schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 Na9b8fd2f335d4fd0b4ec122797f2be90 schema:name pubmed_id
127 schema:value 15558272
128 rdf:type schema:PropertyValue
129 Nb69cb01dec50439195918c6552f296b3 schema:name doi
130 schema:value 10.1007/s00253-004-1720-5
131 rdf:type schema:PropertyValue
132 Nc4e2d82eb5d04707897e9b6d56a32795 schema:name dimensions_id
133 schema:value pub.1030570228
134 rdf:type schema:PropertyValue
135 Ncde3a1d2044a4c7788575b7c6e838c3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Cholesterol
137 rdf:type schema:DefinedTerm
138 Nd0849522413b452baa75a30c56c5e8b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Hydroxymethylglutaryl-CoA Reductase Inhibitors
140 rdf:type schema:DefinedTerm
141 Ne24fca86051e45d9908dae789dab98c8 schema:volumeNumber 66
142 rdf:type schema:PublicationVolume
143 Ne8dc542f1af747a18e3cd4a960683d7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Humans
145 rdf:type schema:DefinedTerm
146 Nf9b14a0a9617476180d0c4cfb4564b3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Gene Expression Regulation
148 rdf:type schema:DefinedTerm
149 Nfe02af8b79914ab8b821c54363b2ac19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Hydroxymethylglutaryl CoA Reductases
151 rdf:type schema:DefinedTerm
152 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
153 schema:name Biological Sciences
154 rdf:type schema:DefinedTerm
155 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
156 schema:name Biochemistry and Cell Biology
157 rdf:type schema:DefinedTerm
158 sg:journal.1083533 schema:issn 0175-7598
159 1432-0614
160 schema:name Applied Microbiology and Biotechnology
161 schema:publisher Springer Nature
162 rdf:type schema:Periodical
163 sg:person.01002553400.17 schema:affiliation grid-institutes:grid.417969.4
164 schema:familyName Panda
165 schema:givenName T.
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002553400.17
167 rdf:type schema:Person
168 sg:pub.10.1007/bf00023395 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022278703
169 https://doi.org/10.1007/bf00023395
170 rdf:type schema:CreativeWork
171 sg:pub.10.1038/308613a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030470122
172 https://doi.org/10.1038/308613a0
173 rdf:type schema:CreativeWork
174 sg:pub.10.1038/343425a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047196635
175 https://doi.org/10.1038/343425a0
176 rdf:type schema:CreativeWork
177 grid-institutes:grid.417969.4 schema:alternateName Department of Chemical Engineering, Indian Institute of Technology, Madras, 600 036, Chennai, India
178 schema:name Department of Chemical Engineering, Indian Institute of Technology, Madras, 600 036, Chennai, India
179 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...